The NEPAD Agency in collaboration with the World Health Organization (WHO) and the organizational support of U.S. Food and Drugs Administration (U.S. FDA) and the Drugs for Neglected Diseases initiative (DNDi) is pleased to announce the First Biennial Scientific Conference on Medicines Regulation in Africa, to take place from 2-3 December 2013 at the Birchwood Hotel in Johannesburg, South Africa. The theme of the conference is “Building Partnerships for Sustainable Capacity Development in Medicines Regulation in Africa.”
The initiative to organize this conference was born of the necessity for African regulatory authorities, researchers, academic institutions and industry to work together to address some of the salient issues affecting delivery of medical products and technologies to the public.
The objectives of the scientific conference are to:
1. Provide a forum to share scientific advances and current best practices in regulatory science disciplines amongst policy makers, regulators, industry experts and scientists.
2. Review current global developments in the regulatory environment and assess their impact on the commercialization of health research products as part of the implementation of the Pharmaceutical Manufacturing Plan for Africa (PMPA).
3. Contribute to global knowledge on regulatory science.
4. Provide input to the third African Medicines Regulatory Authorities Conference.
Please find the conference program, as well as details for abstract submissions and registration, here.